1. Concise Review: Challenges in Regenerating the Diabetic Heart: A Comprehensive Review
   Venkata R. Satthenapalli et al, 2017, Stem Cells CrossRef
2. Febuxostat Modulates MAPK/NF-κBp65/TNF-α Signaling in Cardiac Ischemia-Reperfusion Injury
   Sana Irfan Khan et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
3. O-GlcNAcylation and cardiovascular disease.
   JaLessa N Wright et al, 2017, Biochem Soc Trans CrossRef
4. Bioinformatics analysis to reveal the key genes related to obstructive sleep apnea
   Xiandong Gu et al, 2018, Sleep Breath CrossRef
5. Protein O-GlcNAcylation in Cardiac Pathologies: Past, Present, Future
   Marine Ferron et al, 2019, Front. Endocrinol. CrossRef
6. An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
   Shi-Hui Law et al, 2019, IJMS CrossRef
7. Adeno-associated Virus 9-mediated Small RNA Interference of TLR4 Alleviates Myocardial Ischemia and Reperfusion Injury by Inhibition of the NF-κB and MAPK Signaling Pathways in Rats
   Ting Xu et al, 2019, CMM CrossRef
8. TLR2 deficiency attenuated chronic intermittent hypoxia-induced neurocognitive deficits
   Wanting Li et al, 2020, International Immunopharmacology CrossRef
9. O-GlcNAcylation in immunity and inflammation: An intricate system (Review).
   Yu Li et al, 2019, Int J Mol Med CrossRef
10. Protein O‐GlcNAcylation in the heart
    Yann Huey Ng et al, 2021, Acta Physiol CrossRef
11. O‑GlcNAcylation contributes to intermittent hypoxia‑associated vascular dysfunction via modulation of MAPKs but not CaMKII pathways.
    Xueling Guo et al, 2021, Mol Med Rep CrossRef
12. The dual role of the hexosamine biosynthetic pathway in cardiac physiology and pathophysiology
    Megan Cairns et al, 2022, Front. Endocrinol. CrossRef
13. Chronic intermittent hypoxia‐induced cardiovascular and renal dysfunction: from adaptation to maladaptation
    Claire Arnaud et al, 2023, The Journal of Physiology CrossRef